Fierce Biotech
Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial
Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two still-ongoing obesity trials.